Expanding the genetic and phenotypic spectrum of ACTA2-related vasculopathies in a Dutch cohort

Lisa M van den Bersselaar1, Judith M A Verhagen1, Jos A Bekkers2

  • 1Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Insights

Pathogenic variants in the ACTA2 gene significantly increase the risk of thoracic aortic aneurysms and dissections. Early recognition is crucial, as aortic events can occur even with normal aortic diameters.

Area of Science:

  • Genetics
  • Cardiology
  • Vascular Biology

Background:

  • Pathogenic/likely pathogenic (P/LP) variants in the ACTA2 gene are linked to a high risk of thoracic aortic aneurysms and aortic dissections.
  • ACTA2-related vasculopathies represent a significant clinical challenge due to their potential for severe cardiovascular events.

Purpose of the Study:

  • To elucidate the clinical outcomes and characteristics of individuals with ACTA2-related vasculopathies.
  • To identify risk factors associated with aortic events in patients carrying P/LP ACTA2 variants.

Main Methods:

  • A retrospective multicenter study involving index patients and relatives with P/LP ACTA2 variants.
  • Data collection via standardized questionnaires and medical record review.

Main Results:

  • The study included 49 individuals from 28 families, with 20 different ACTA2 variants identified.
  • Aortic events occurred in 65% of participants, with male sex and hypertension being significant risk factors.
  • Aortic dissections were observed even in individuals with aortic diameters <45 mm, with a mean age of first event at 49.0 years.

Conclusions:

  • P/LP ACTA2 variants are strongly associated with an increased risk of aortic events and age-related penetrance.
  • Early diagnosis and awareness of ACTA2-related vasculopathies are critical for timely intervention.
  • Healthcare providers should consider the risk of aortic dissection even in patients with normal aortic dimensions.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
32
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
27